Baccarini
|
Max Perutz Labs
|
Deciphering the MAPK pathway in vivo
|
Belkhadir
|
GMI
|
Plant cell signalling at the interface of growth and defences
|
Blaas
|
Max Perutz Labs
|
Early interactions of viruses with host cells
|
Busslinger
|
IMP
|
Stem cell commitment in haematopoiesis
|
Clausen
|
IMP
|
Molecular mechanisms of protein quality control
|
Dagdas
|
GMI
|
The role of autophagy in plant development and stress tolerance
|
Decker
|
Max Perutz Labs
|
Host responses and innate immunity to bacteria
|
Elling
|
IMBA
|
Functional genomics in embryonic stem cells
|
Foisner
|
Max Perutz Labs
|
Lamins in nuclear organization and human disease
|
Fuchs
|
Max Perutz Labs
|
Stress response in simple epithelia
|
Haubensak
|
IMP
|
Circuit mechanics of emotional behaviour
|
Hofbauer
|
Max Perutz Labs
|
Consequences of carnitine deficiency and CSF-1 inhibition
|
Ikeda
|
IMBA
|
Linear ubiquitination in inflammation, cell death and autophagy
|
Ivessa
|
Max Perutz Labs
|
Protein biogenesis and degradation from the ER
|
Knoblich
|
IMBA
|
Brain development and disease
|
Kovarik
|
Max Perutz Labs
|
Signaling and gene expression in inflammation
|
Kowalski
|
Max Perutz Labs
|
Molecular and structural biology of picornaviruses
|
Kuchler
|
Max Perutz Labs
|
Host-Pathogen Interactions & Mechanisms of Drug Resistance & Fungal Pathogenesis
|
Leonard
|
Max Perutz Labs
|
Structural Biology of Lipid-Activated Signal Transduction
|
Martens
|
Max Perutz Labs
|
Molecular Mechanisms of Autophagy
|
Martinez
|
Max Perutz Labs
|
Biochemistry, physiology and disease of the tRNA splicing pathway in mammalian cells
|
Obenauf
|
IMP
|
Molecular mechanisms of metastasis and drug resistance
|
Ogris
|
Max Perutz Labs
|
PP2A enzyme biogenesis and monoclonal antibodies
|
Pavri
|
IMP
|
Molecular mechanisms of antibody diversification
|
Penninger
|
IMBA
|
Modeling human disease
|
Skern
|
Max Perutz Labs
|
Interactions between viruses and cells
|
Swarts
|
GMI
|
Tree-ring genomics
|
Versteeg
|
Max Perutz Labs
|
Ubiquitin-mediated regulation of immune signaling
|
Zuber
|
IMP
|
Finding and probing cancer drug targets using advanced RNAi technologies
|